Cystic Fibrosis Foundation Practice Guidelines for the Management of Infants with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome during the First Two Years of Life and Beyond
To access this article, please choose from the options below
Please see Author Disclosures at the end of this article.
PII: S0022-3476(09)00883-X
doi:10.1016/j.jpeds.2009.09.003
© 2009 Mosby, Inc. All rights reserved.
